Eagle Asset Management’s Tenet Healthcare THC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
$11M Buy
66,605
+29,190
+78% +$4.41M 0.06% 279
2024
Q2
$4.99M Buy
+37,415
New +$4.5M 0.03% 392
2023
Q4
Sell
-61,079
Closed -$4.02M 594
2023
Q3
$4.02M Buy
61,079
+1,368
+2% +$102K 0.02% 382
2023
Q2
$4.86M Buy
+59,711
New +$4.25M 0.03% 357
2022
Q4
Sell
-153,075
Closed -$7.89M 561
2022
Q3
$7.89M Sell
153,075
-4,197
-3% -$249K 0.05% 269
2022
Q2
$8.27M Sell
157,272
-120,111
-43% -$8.36M 0.05% 273
2022
Q1
$23.8M Buy
277,383
+13,598
+5% +$1.12M 0.12% 183
2021
Q4
$21.6M Sell
263,785
-1,807
-0.7% -$132K 0.09% 212
2021
Q3
$17.6M Sell
265,592
-39,130
-13% -$2.78M 0.08% 231
2021
Q2
$20.4M Buy
+304,722
New +$18.9M 0.09% 234

Other funds holding THC

Eagle Asset Management's THC Position: Q3 2024 in Review

Eagle Asset Management increased its Tenet Healthcare (THC) stake by 78% in Q3 2024, buying an estimated $4.41M and bringing the position to 66,605 shares worth $11M. The position accounts for 0.06% of the portfolio, ranked #279.

Eagle Asset Management first reported a position in THC in Q2 2021 and has held it in 10 quarters since. The position peaked at $23.8M in Q1 2022. 602 funds tracked by Wall St. Rank hold THC as of Q3 2024.

  • Eagle Asset Management held 66,605 shares of Tenet Healthcare worth $11M as of Q3 2024.
  • Eagle Asset Management bought 29,190 Tenet Healthcare shares in Q3 2024, an estimated $4.41M.
  • Tenet Healthcare made up 0.06% of Eagle Asset Management's portfolio in Q3 2024, its #279 holding.
  • Eagle Asset Management first reported a position in Tenet Healthcare in Q2 2021 and has held it in 10 quarters since.
  • Eagle Asset Management's Tenet Healthcare position peaked at $23.8M in Q1 2022.
  • 602 funds tracked by Wall St. Rank held Tenet Healthcare as of Q3 2024.

Based on Eagle Asset Management's 13F filing for Q3 2024, filed 12 Nov 2024.